These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19461157)
21. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma. Tsuchida R; Miyauchi J; Shen L; Takagi M; Tsunematsu Y; Saeki M; Honna T; Yamada S; Teraoka H; Kato JY; Mizutani S Jpn J Cancer Res; 2002 Sep; 93(9):1000-6. PubMed ID: 12359053 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576 [TBL] [Abstract][Full Text] [Related]
23. Significance of Jab1 expression in human esophageal squamous cell carcinoma. Wang F; Wang Y; Yu X; Yang D; Wang Z; Lu C; Yuan Z; Xiao M; Shen A J Clin Gastroenterol; 2009 Jul; 43(6):520-6. PubMed ID: 19349901 [TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effect of arsenic trioxide on proliferation of human hepatocellular carcinoma cell line SMMC-7721 and the mechanism]. Cui XP; Wang Y; Lu MD; Li P; Shen AG Ai Zheng; 2007 Dec; 26(12):1304-8. PubMed ID: 18076791 [TBL] [Abstract][Full Text] [Related]
25. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606 [TBL] [Abstract][Full Text] [Related]
26. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas. Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702 [TBL] [Abstract][Full Text] [Related]
27. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer. Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449 [TBL] [Abstract][Full Text] [Related]
28. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid Rodolico V; Cabibi D; Pizzolanti G; Richiusa P; Gebbia N; Martorana A; Russo A; Amato MC; Galluzzo A; Giordano C Cancer; 2007 Sep; 110(6):1218-26. PubMed ID: 17685465 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406 [TBL] [Abstract][Full Text] [Related]
30. Interaction of the stress protein p8 with Jab1 is required for Jab1-dependent p27 nuclear-to-cytoplasm translocation. Malicet C; Hoffmeister A; Moreno S; Closa D; Dagorn JC; Vasseur S; Iovanna JL Biochem Biophys Res Commun; 2006 Jan; 339(1):284-9. PubMed ID: 16300740 [TBL] [Abstract][Full Text] [Related]
31. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression. Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612 [TBL] [Abstract][Full Text] [Related]
32. Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27. Gao L; Huang S; Ren W; Zhao L; Li J; Zhi K; Zhang Y; Qi H; Huang C Med Oncol; 2012 Dec; 29(4):2499-504. PubMed ID: 22311264 [TBL] [Abstract][Full Text] [Related]
33. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth. Shiraso S; Katayose Y; Yamamoto K; Mizuma M; Yabuuchi S; Oda A; Rikiyama T; Onogawa T; Yoshida H; Hayashi H; Ohtsuka H; Motoi F; Egawa S; Kato J; Unno M Anticancer Res; 2009 Jun; 29(6):2015-24. PubMed ID: 19528460 [TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262 [TBL] [Abstract][Full Text] [Related]
37. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Caballero OL; Resto V; Patturajan M; Meerzaman D; Guo MZ; Engles J; Yochem R; Ratovitski E; Sidransky D; Jen J Oncogene; 2002 May; 21(19):3003-10. PubMed ID: 12082530 [TBL] [Abstract][Full Text] [Related]
38. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252 [TBL] [Abstract][Full Text] [Related]
39. Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1. Chopra S; Fernandez De Mattos S; Lam EW; Mann DJ J Biol Chem; 2002 Sep; 277(36):32413-6. PubMed ID: 12119282 [TBL] [Abstract][Full Text] [Related]
40. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma. Pan Y; Zhang Q; Tian L; Wang X; Fan X; Zhang H; Claret FX; Yang H Cancer Res; 2012 Apr; 72(7):1890-900. PubMed ID: 22350412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]